Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Direclidine - Neurocrine Biosciences

Next Previous
Drug Profile

Direclidine - Neurocrine Biosciences

Alternative Names: HTL-0016878; NBI-1117568; NBI-568

Latest Information Update: 07 Apr 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Heptares Therapeutics
  • Developer AbbVie; Neurocrine Biosciences; Nxera Pharma
  • Class Antidementias; Antipsychotics; Carbamates; Piperazines; Pyrazoles; Pyrrolidines; Small molecules; Spiro compounds
  • Mechanism of Action Muscarinic M4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase III Schizophrenia
  • Phase II Bipolar I disorders
  • No development reported Alzheimer's disease

Most Recent Events

  • 24 Dec 2025 Phase-II clinical trials in Bipolar I disorders in USA (PO) (NCT07288320)
  • 13 Nov 2025 Neurocrine Biosciences plans a phase III trial for Schizophrenia (Treatment-experienced) in December 2025 (Oral, Capsule) (NCT07227818)
  • 16 Sep 2025 Chemical structure information added.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top